chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient presented back to the pharmacy on 10/10/2018 in the evening and her left arm was warm to touch and slightly swollen. Appeared a light pink color. Patient said last year with the high dose vaccine her arm hurt and was a little red, this year seems to be worse. She took some naproxen to decrease inflammation and also put ice on the arm. I did tell her she can take some BENADRYL which she was to do this evening. Told her if symptoms worsen to be seen by Dr. in the office.
Patient reported feeling a "burning" sensation on her tongue and face. No shortness of breath or trouble swallowing. No dizziness. Her vital signs were stable aside from elevated blood pressure. She said it started 5 minutes after the injection but she waited till 30 minutes passed before reporting it. A doctor was called who ordered 10 mg Zyrtec sublingual. She was transferred to a doctor's office. Her blood pressure was much lower and her symptoms resolved 15 minutes after the Zyrtec was given.
Patient received pneumonia from us on 11/29/12. He received the PNEUMOVAX in his right deltoid. As of today 12/1/12 his arm looked very swollen and some of his skin looked like it was peeling. He was evaluated by a physician and then prescribed some cefadroxil and SILVADENE cream.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY ACUTE STROKE OF THALAMUS, UNSPECIFIED TYPE AND ARTERY HYPOXEMIA 6/1/2022, 6/29/2022, 6/30/2022. & 2/8/2023 - RECURRENCE OF SAME SYMPTOMS
Patient complains of severe pain in arm at site of injection developing in the night after he had vaccine. Area is red, slightly hot to touch, approximately size of large orange. No swelling above or below red area.
This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (soreness from both doses of the vaccine, which lasted only for a day after each shots were given) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Feb 6, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Mar 6, 2021, received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced pain in extremity (soreness from both doses of the vaccine, which lasted only for a day after each shots were given). At the time of the report, pain in extremity (soreness from both doses of the vaccine, which lasted only for a day after each shots were given) resolved.  No relevant concomitant medications or treatment information provided. Action taken with mRNA-1273 in response to the events: not applicable. This case linked to MOD-2021-114518 (patient link).
booster; chills; fatigue; arm pain; fever; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Unknown manufacturer), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious), outcome "unknown", described as "booster"; CHILLS (non-serious), outcome "unknown", described as "chills"; FATIGUE (non-serious), outcome "unknown", described as "fatigue"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "arm pain"; PYREXIA (non-serious), outcome "unknown", described as "fever".  Additional information: Event took place 24-36 hours after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a physician concerning an approximately 60 year old pt who in approximately October 2002, was vaccinated in the arm with a dose of pneumoccocal vaccine 23 polyvalent (lot# 642722/0165M). Concomitant therapy, that same day, included a dose of influenza virus vaccine in the opposite arm. Within hours of vaccination, in approximately October 2002, the pt developed a "big time reaction" from the deltoid to the elbow. These reaction persisted for 3 to 5 days. The pt received palliative treatment. The physician reported that the pt had prior vaccination with pneumococcal vaccine 23 polyvalent over 5 years ago. The reporter expressed a concern with the lot. The records of testing prior to release of this lot have been checked by GMP compliance and found to be satisfactory. The lot complies with the standards of the CBER and was released. The pt sought unspecified medical attention. Additional information has been requested. This is one of a total of four patients. Three other patients had similar reactions after pneumococcal vaccine 23 polyvalent (WAES numbers 0210USA02060, 0306USA02764 and 0306USA02766).
Next day: physical chills, headache, body & joint aches, fatigue. Arm rash and swelling. Lymph nodes under arm swollen and sore. Rash hot to touch. Wednesday: lip tingling. Thursday: full blown lip sore. Saturday morning: ulcer type sore inside vagina. Constipation.  Headaches daily.  Monday 2/15 went to urgent care. Prescribed prednisone. Blood work ran.
reddened, swollen,hot site of injection. itching- leading to dx of cellulitis. oral antibiotics.
12/31/2001-Received vaccine 01/01/2002-developed red spot than red rash on inner thigh which spread upward to trunk /01/02/2002 hands swollen, lower lips swollen, no breathing problems. took Benadryl po. saw M.D. 01/02/2002-No cause of reaction determined, told to not get flu & pneumonia vaccines again.
no full range of motion of the neck; tenderness; patient experienced neck soreness, and it got worse; felt like lymph node pressure; neck soreness; tender to touch on the left side of neck; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE TIGHTNESS (no full range of motion of the neck), NECK PAIN (neck soreness), TENDERNESS (tender to touch on the left side of neck), TENDERNESS (tenderness) and NECK PAIN (patient experienced neck soreness, and it got worse) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004CZ1A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced NECK PAIN (neck soreness), TENDERNESS (tender to touch on the left side of neck), NECK PAIN (patient experienced neck soreness, and it got worse) and LYMPH NODE PAIN (felt like lymph node pressure). On 06-May-2021, the patient experienced MUSCLE TIGHTNESS (no full range of motion of the neck) and TENDERNESS (tenderness). The patient was treated with IBUPROFEN (oral) at an unspecified dose and frequency. At the time of the report, MUSCLE TIGHTNESS (no full range of motion of the neck), NECK PAIN (neck soreness), TENDERNESS (tender to touch on the left side of neck), TENDERNESS (tenderness), NECK PAIN (patient experienced neck soreness, and it got worse) and LYMPH NODE PAIN (felt like lymph node pressure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medication was reported
Vomiting and kinda almost fainted. After vomiting I was fine. Lasted roughly 5-10 min. Feeling faint could have been cause by over panicking about vomiting and the vaccine but I though I would share.
On right shoulder all the way down to her elbow, she is experiencing hot temperature, swollen and pain. It had occurred that same day 6 hours alter. No shortness of breath. She had low grade fever on 9/27/2020 but it had subsided.  Arm had a little bit of itching. Symptoms are still present, but not as strong as on Saturday.  In the back of the right arm is sore.
Possible late second dose of Shingrix; This non-serious case was reported by a physician via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: Possible late second dose of Shingrix). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 27-JUL-2023 and 28-JUL-2023 The reporter reported possible late second dose of Shingrix. The vaccine administration facility was the same as primary reporter. No additional adverse event (AE) details available.  The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule.
Pt recvd Engerix-B vax 5NOV90; 24 hrs post vax exp intense itching @ site of inject & urticaria on abdomen; tx DPH; events resolved in about 3 wks;
This child had joint pain occurring within 24 hours after being vaccinated. Intermittent joint pain lasting 2 1/2 months. Treated with Tylenol.
Information has been received from a health professional concerning a 27 year old mother, with no medical history and no allergies who's infant, was vaccainted with a dose of Rotavirus vaccine (lot number 652964/0145F) on 7/28/06. There was no concomitant medications. Within 24 hours of 7/28/06 the pt was severely ill with diarrhea, cramping, and nausea for 3 or 4 days that was noted to be possibly from shedding. It was noted that the pt nursed her infant every 2 to 3 hours. It was reported that the pt recovered. No lab or diagnostic tests were performed. Unspecified medical attention was sought. no product quality complaint was involved. Follow up information from a health professional indicated that the vaccainted child was perfectly fine and had no symptoms of diarrhea. The reporter thought that it would be strange for the mother to have developed diarrhea in such a short period of time of 24 hours after the infant receiving the vaccine and that most adults would be immune to Rotavirus vaccine. The reporter noted that no family member were immunocompromised. The reporter also noted that the diarrhea could have been due to a viral illness that the family had acquired just coincidentally at the time that the child was vaccinated with Rotavirus vaccine.  Follow-up information from a health professional indicated that the patient was breast feeding the same day as the baby was vaccinated with a dose of ROTATEQ and developed severe diarrhea.  It was reported that there were no culture work done since she did not seek medical attention or notify until the baby's next immunization.  Additional information is not expected.
edema with blanchable redness around the injection site 7 cm by 11 cm in diameter, pt received decadron, recheck tomorrow
This is a spontaneous report from a contactable consumer. A 55-year-old male patient received PREVNAR 13, via an unspecified route of administration, on an unspecified date, at single dose, for immunisation. Relevant medical history and concomitant medications were not reported. The patient experienced puffy arm at injection site 2 days after vaccination. Outcome of the event was unknown.
Doctor had told me to give vaccine, I checked the immunization record and the first vaccine did not appear on the sheet, I did not see it as well as doctor, therefore I gave the vaccine and documented it
Patient reported severe tachycardia, palpitations for 12 hours prior to event, and reported fainting/losing consciousness at 6:00am Monday, March 4. Patient does not recall passing out, went back to bed, and when reawakening at 8:30am, reported injury to head, bruising and scraping to head and chin from fall from fainting. Lesser adverse events: patient reported severe flu-like symptoms, nausea, fever, chills for a couple days leading up to event. Patient reported all symptoms of tachycardia and flu-like symptoms subsiding when reawakening at 8:30am Monday March 4.
1st dose in 2020, 2nd dose today; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 80-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix  (received first dose in December 2020).   On 07-APR-2023, the patient received the 2nd dose of Shingrix. On 07-APR-2023, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too long (Verbatim: 1st dose in 2020, 2nd dose today). The outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK receipt date: 7-Apr-2023 The pharmacist reported that the second dose was given on the day of reporting to another agent after transferring the health care professional to them to answer their medical information questions. Follow up email was sent by her to safety team. The vaccine administration facility was the same as primary reporter. The patient received second dose of Shingrix later than the recommended interval, which led to lengthening of vaccine schedule.
Fever (101-102 degrees) developed after 12 hours receiving flu-shot associated with Headaches and achiness and pain in the muscles. Treated with Motrin and Advil. On 10/18/2013, 40+ hours after the flu-shot, felt weak with runny nose and sore throat. 10/19/2013, sore throat worsened and dry cough started. 10/21/2013, fever's back and cough worsened. 10/22/2013, trouble to breath with severe cough. Unable to work, visited doctor's office and diagnosed with acute  bronchitis. Put on the following meds: Levofloxacin; Naproxen; AND Hydroxyzine. 10/23/2013, severe hive developed all over body, added Benadryl and switched to Azithromycin. 10/24/2013, hives remains, cough worsening.
EPILEPSY, UNSPECIFIED 4/6/2023 EPILEPSY, UNSPECIFIED    LEFT FACIAL MUSCLE WEAKNESS LEFT FACIAL MUSCLE WEAKNESS 4/6/2023 EPILEPSY, UNSPECIFIED    LEFT FACIAL MUSCLE WEAKNESS
Within 30 seconds I had difficulty swallowing, my heart rate jumped to 140 beats per minute with oxygen levels at 94 as measured by the pulse ox I brought with me, and I developed a headache. A few minutes after that my face and arms became itchy and I became dizzy.  I talked to an attendant who told me that headaches weren't a usual symptom of allergic reactions and to honk my horn if I got worse and felt that EMS needed to check me out. I couldn't really risk getting medical bills so I decided to just use my asthma inhaler to hopefully open up my throat a bit more and stayed in the parking lot for 45 minutes. When it became clear I was at least not going to get worse  I drove home. When I got out of the car my legs were weak and I still had a headache. Symptoms did not resolve until about 2.5 hours after vaccination.
10:00am felt my throat start to slowly constrict and chest pains.  Arrived at the emergency room at 10:34am.  Diagnosis:  Atypical chest pain; Allergic reaction with angioedema secondary to IM drug and Coviod Vaccine.  IV started and benedryl and epinephrine given.  Diagnostics:  CBC w/auto diff; CMP; POC-BNP; POC-TPI; Chest Portable; Chest X-ray; EKG; Pulse ox.  Released 4:14pm.  Rx:  Rest, Medrol Dosepak, Acetaminophen, Motrin and Benadryl.
Red Rash on left side of torso; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red Rash on left side of torso) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red Rash on left side of torso). The patient was treated with CORTISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (Red Rash on left side of torso) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 12-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Red Rash on left side of torso) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Red Rash on left side of torso). The patient was treated with CORTISONE for Adverse event, at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (Red Rash on left side of torso) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Feels so bad, I was in a fog; my bowels wanted to move, but wouldn't move; fluish; moaning; Shaking; throwing up all over the place; banging headache; had chills that she was shaking; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Feels so bad, I was in a fog), DEFAECATION DISORDER (my bowels wanted to move, but wouldn't move), INFLUENZA LIKE ILLNESS (fluish), MOANING (moaning) and TREMOR (Shaking) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. M012120N) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 01-Nov-2020.    On 21-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced FEELING ABNORMAL (Feels so bad, I was in a fog), DEFAECATION DISORDER (my bowels wanted to move, but wouldn't move), INFLUENZA LIKE ILLNESS (fluish), MOANING (moaning), TREMOR (Shaking), VOMITING (throwing up all over the place), HEADACHE (banging headache) and CHILLS (had chills that she was shaking). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of UNK dosage form. On 22-Jan-2021, INFLUENZA LIKE ILLNESS (fluish) had resolved. At the time of the report, FEELING ABNORMAL (Feels so bad, I was in a fog), DEFAECATION DISORDER (my bowels wanted to move, but wouldn't move), MOANING (moaning), TREMOR (Shaking), VOMITING (throwing up all over the place), HEADACHE (banging headache) and CHILLS (had chills that she was shaking) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  The patient reported that she felt much better on 23 Jan 2021.   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: No new significant information was provided. The reporter's email I address was updated.
fluid build up at prior injection site; arm pain; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE REACTION (fluid build up at prior injection site) and PAIN IN EXTREMITY (arm pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (fluid build up at prior injection site) and PAIN IN EXTREMITY (arm pain). At the time of the report, VACCINATION SITE REACTION (fluid build up at prior injection site) and PAIN IN EXTREMITY (arm pain) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Patient still taking physical therapy due to prior vaccination.
INCREASED SHORTNESS OF BREATH; FEELS BAD; FEVER; NIGHT SWEATS; HEADACHE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's concurrent conditions included penicillin allergy, alcohol use, and somker, and other pre-existing medical conditions included the patient no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported.  On 13-APR-2021, the subject experienced night sweats. On 13-APR-2021, the subject experienced headache. On 14-APR-2021, the subject experienced feels bad. On 14-APR-2021, the subject experienced fever. On an unspecified date, the subject experienced increased shortness of breath. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feels bad, night sweats, headache, and fever, and the outcome of increased shortness of breath was not reported. This report was non-serious.; Sender's Comments: V.0 Medical assessment comment not required as per standard procedure as case was assessed as non-serious.
My right hand is in constant pain since vaccination. I have no strength and nerve pain in the elbow, neck and below the elbow. I cannot sleep because it is the worst when I am lying down or sitting down.  I have seen my family doctor three times, I just did a series of x-rays. I saw a neurologist on 8/8 and going to see another neurologist on 8/12. The neurologist said that it was definitely nerve inflammation caused either by the shot or by reaction to the vaccine.
extreme nausea, major headache, extreme fatigue, dizziness, extreme aches.....I haven't missed work in 25 years, this was so intense I called my husband home from work and had to stay home in bed for 24 hours
Chills about 16 hours after vaccine.. lasted one hour   sore arm  2 days    . fatigue for 3 days ,  longer sleeping than usual.
I began experiencing what felt like severe cramping in my left calf, which left me unable to walk comfortably. That let up after about 4 days. Several weeks later, I experienced less severe cramping in my right calf, which also went away after several days. Then my left leg cramped up again, at which point I went to the doctor and they ordered a doplar of my left calf, which revealed a clot.
I began to have fever and chills about 8 that night after I got home from work.  My fever and chills continued through the next day and night.  My highest temperature was102.3.  I also experienced fatigue, muscle and joint pain, and weakness and lightheadedness.  The fatigue, muscle aches, weakness/lightheadedness  is still there along with pain and swelling at the injection site.